Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
Auteurs : Bines J, Clark E, Barton C, Restuccia E, Procter M, Sonnenblick A, Fumagalli D, Parlier D, Arahmani A, Baselga J, Viale G, Reaby LL, Frank E, Gelber Rd, Piccart-Gebhart M, Jackisch C, Petersen JA
Jaar : 2021
Journal : Br J Cancer
Volume : 125
Pagina's : 38-47